Literature DB >> 28374173

Structural Stability of Streptococcal Serum Opacity Factor.

Dedipya Yelamanchili1, Baiba K Gillard1,2, Antonio M Gotto1,2, Henry J Pownall1,2, Corina Rosales3,4.   

Abstract

Streptococcal serum opacity factor (SOF) is a protein that clouds the plasma of multiple mammalian species by disrupting high density lipoprotein (HDL) structure. Intravenous infusion of low dose SOF (4 µg) into mice reduces their plasma cholesterol concentrations ~ 40% in 3 h. Here we investigated the effects of pH, ionic strength, temperature, and denaturation with guanidinium chloride (GdmCl) on SOF stability and its reaction vs HDL. SOF stability was tested by pre-incubation of SOF at various temperatures, pH's, and GdmCl concentrations and measuring the SOF reaction rate at pH 7.4 and 37 °C. SOF retained activity at temperatures up to 58 °C, at pH 4 to 10, and in 8.5 M GdmCl after being returned to standard buffer conditions. The effects of GdmCl, pH, and ionic strength on the SOF reaction rates were also measured. SOF was inactive at GdmCl ≥ 1 M; SOF was most active at pH 5, near its isoelectric point and at an ionic strength of 3 (in NaCl). These data reveal that SOF is a stable protein and suggest that its activity is determined, in part, by the effects of pH and ionic strength on its overall charge relative to that of its reaction target, HDL.

Entities:  

Keywords:  Cholesterol; High density lipoproteins; Protein stability; Serum opacity factor

Mesh:

Substances:

Year:  2017        PMID: 28374173      PMCID: PMC5448415          DOI: 10.1007/s10930-017-9711-4

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  15 in total

1.  Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol.

Authors:  Baiba K Gillard; Corina Rosales; Biju K Pillai; Hu Yu Lin; Harry S Courtney; Henry J Pownall
Journal:  Biochemistry       Date:  2010-10-25       Impact factor: 3.162

2.  Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes.

Authors:  H S Courtney; D L Hasty; Y Li; H C Chiang; J L Thacker; J B Dale
Journal:  Mol Microbiol       Date:  1999-04       Impact factor: 3.501

3.  Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism.

Authors:  Corina Rosales; Niket Patel; Baiba K Gillard; Dedipya Yelamanchili; Yaliu Yang; Harry S Courtney; Raul D Santos; Antonio M Gotto; Henry J Pownall
Journal:  Biochemistry       Date:  2015-04-02       Impact factor: 3.162

4.  Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.

Authors:  Corina Rosales; Daming Tang; Baiba K Gillard; Harry S Courtney; Henry J Pownall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-19       Impact factor: 8.311

5.  Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.

Authors:  Corina Rosales; Baiba K Gillard; Harry S Courtney; Francisco Blanco-Vaca; Henry J Pownall
Journal:  Biochemistry       Date:  2009-08-25       Impact factor: 3.162

6.  Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption.

Authors:  Baiba K Gillard; Harry S Courtney; John B Massey; Henry J Pownall
Journal:  Biochemistry       Date:  2007-10-17       Impact factor: 3.162

7.  Properties of the products formed by the activity of serum opacity factor against human plasma high-density lipoproteins.

Authors:  Henry J Pownall; Harry S Courtney; Baiba K Gillard; John B Massey
Journal:  Chem Phys Lipids       Date:  2008-09-16       Impact factor: 3.329

8.  Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.

Authors:  Henry J Pownall; Brian D Hosken; Baiba K Gillard; Catherine L Higgins; Hu Yu Lin; John B Massey
Journal:  Biochemistry       Date:  2007-05-27       Impact factor: 3.162

9.  Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I.

Authors:  Mikyung Han; Baiba K Gillard; Harry S Courtney; Kathryn Ward; Corina Rosales; Htet Khant; Steven J Ludtke; Henry J Pownall
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

10.  IPC - Isoelectric Point Calculator.

Authors:  Lukasz P Kozlowski
Journal:  Biol Direct       Date:  2016-10-21       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.